Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Defilade Capital Management, L.P.
Form 13F · Q2 2026

Defilade Capital Management, L.P.

CIK 2088557Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$747M
Reported book value
39
Positions
3
Quarters on record
Top 50
Positions

Defilade Capital Management, L.P. — holdings

Top 39 positions of 39, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1LLY Eli Lilly & Co39,086+88.9%$47M6.3%
2PFE Pfizer Inc1.8M+21.0%$43M5.7%
3VEEV Veeva Sys Inc236,709—$42M5.6%
4BMRN Biomarin Pharmaceutical Inc682,005—$39M5.2%
5PTCT Ptc Therapeutics Inc433,699+15.3%$35M4.7%
6BAXTER INTL INC Baxter Intl Inc1.5M—$31M4.2%
7INSM Insmed Inc281,838+44.6%$30M4.0%
8ZBH Zimmer Biomet Holdings Inc317,426−45.2%$27M3.7%
9PODD Insulet Corp176,932—$27M3.6%
10TMO Thermo Fisher Scientific Inc51,934—$26M3.5%
11ABT Abbott Laboratories285,778—$26M3.5%
12ASND Ascendis Pharma A/S94,843—$25M3.4%
13SOLV Solventum Corp316,454—$24M3.3%
14MDT Medtronic Plc303,301—$24M3.2%
15ELAN Elanco Animal Health Inc864,080−7.2%$21M2.8%
16AGIO Agios Pharmaceuticals Inc546,848—$20M2.7%
17NVST Envista Holdings Corporation726,108—$19M2.6%
18RVMD Revolution Medicines Inc82,827−73.8%$16M2.1%
19ICU MED INC Icu Med Inc105,700−58.4%$15M2.1%
20COGT Cogent Biosciences Inc393,441+11.6%$15M2.0%
21LNTH Lantheus Hldgs Inc132,662−46.8%$15M2.0%
22OCUL Ocular Therapeutix Inc1.5M+0.2%$15M2.0%
23ELDN Eledon Pharmaceuticals Inc3.5M−1.1%$14M1.9%
24TYRA Tyra Biosciences Inc376,870—$12M1.6%
25OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc924,758−38.5%$12M1.5%
26ORIC Oric Pharmaceuticals Inc1.0M+24.3%$11M1.5%
27LRMR Larimar Therapeutics Inc3.7M—$11M1.5%
28GMED Globus Med Inc139,637−60.6%$11M1.5%
29ENOV Enovis Corporation531,945—$11M1.5%
30EVMN Evommune Inc793,145+16.9%$11M1.4%
31TFX Teleflex Incorporated80,118—$10M1.4%
32DNLI Denali Therapeutics Inc391,866−71.2%$10M1.3%
33GKOS Glaukos Corp66,519—$9M1.2%
34STAA Staar Surgical Co322,126—$9M1.2%
35PACS Pacs Group Inc215,675−64.3%$9M1.2%
36CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In239,440—$9M1.2%
37LIVN Livanova Plc107,373—$9M1.2%
38BDTX Black Diamond Therapeutics I1.7M—$3M0.4%
39MREO Mereo Biopharma Group Plc7.6M+0.0%$2M0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.